Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2015-09-29

Clinical Trial Update: tVNS for Depression [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update for transcutaneous vagus nerve stimulation (tVNS) in depressive disorder covering Phase 1 and Phase 2; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Santa Casa Medical School | Conditions: Depressive Disorder | Phase 1, Phase 2 | Status: UNKNOWN